News & Events

Events & Conferences

2024 GI APP Summit – October 10-22, 2024

Join us for our 3rd annual Advanced Practice Provider Summit taking place October 10-11, 2024 at the Graduate Hotel in Minneapolis. Gastroenterology has many specialized niches that continue to be at the forefront of a rapidly evolving field. This course will provide APPs and other healthcare providers with the latest and most up to date guidelines, and diagnostic and management modalities in these specialized niches that are not typically discussed in formal training.

Learn more and register

In the News

  • Dr. Mary Thomson featured in Healio Gastroenterology Article
    Dr. Mary Thomson was featured in Healio Gastroenterology’s article, "Less than 25% of patients with cirrhosis, low bone density are treated for osteoporosis."The article refers to a publication featuring Drs. Mary Thomson, Nicholas Lim, and Jack Lake titled, "Low screening rates and high prevalence of osteoporosis in cirrhosis: A real-world retrospective analysis." View the article and publication.
  • Dr. Khoruts quoted in press release
    On July 5th, the medical school released a press release onDr. Alexander Khoruts’ study quoting, “University of Minnesota-led study demonstrates safety of microbiota transplant therapy in stem cell transplant and leukemia patients.” Read the publication and press release.
  • Dr. Alex Khoruts interviewed by the Financial Times 
    Dr. Alexander Khoruts was interviewed by the Financial Times in their article, “U.S. regulators approve first human pill derived from fecal matter” for the treatment of C. difficile. Read the article here.
  • Dr. Nicholas Lim talked to AARP in “7 Ways to Protect Your Liver”
    Dr. Nicholas Lim talked to AARP about the rise of alcohol-related liver disease and NAFLD, as well as avoiding herbal supplements. Read the article here.
  • Dr. Justin Howard’s Expert Alert for World IBD Day on May 19
    Dr. Justin Howard shared the importance of raising awareness of IBD through the Medical School’s Expert Alert on World IBD Day. Read more here.
  • Dr. Thomas Leventhal featured in "Talking organ donation with U of M"
    Dr. Thomas Leventhal was featured in the “Talking organ donation with U of M” press release regarding the importance of organ donation for National Donate Life Month in April.
  • Dr. Joshua Sloan comments in Gastroenterology & Endoscopy News article
    Dr. Joshua Sloan was recently quoted in the Gastroenterology & Endoscopy News article, "More Data Support Dupilumab for Severe EoE." Read the article here.
  • Dr. Nicholas Lim interviewed on KARE11
    Dr. Nicholas Lim was interviewed by KARE11 on alcohol-related disease as the leading reason for liver transplants. Watch the interview on KARE11.
  • Dr. Guru Trikudanathan develops prediction model for intervention needs in acute necrotizing pancreatitis following discharge
    Guru Trikudanathan, MBBS, led researchers in a single-center study to develop a prediction model based on clinical metrics and imaging characteristics using a prospective data set meticulously collected for over ten years. The study was published in Pancreatolgy. Read More
  • Stuart Amateau, MD, PhD Named Director, Division of Gastroenterology, Hepatology and Nutrition
    Join us in congratulating Stuart Amateau, MD, PhD, in his new role as Director, Division of the Gastroenterology, Hepatology and Nutrition (“GI”). Dr. Amateau has served as Interim Division Director since February 2022, and the GI Division is thrilled that he will continue his outstanding leadership and inspiring commitment to excellence in teaching, research, and patient care. Read More
Recent Faculty Publications

Hirsch W, Megna B, Adeyi O, Lim N. Macrophage activation syndrome with acute hepatitis in a patient with adult-onset immunodeficiency with anti-interferon gamma antibodies: a case report. J Med Case Rep. 2024 Jan 5;18(1):6. doi: 10.1186/s13256-023-04245-w. PMID: 38178160; PMCID: PMC10768153.
Karna R. Continuing Medical Education Questions: January 2024. Am J Gastroenterol. 2024 Jan 1;119(1):27. doi: 10.14309/ajg.0000000000002613. Epub 2023 Sep 27. PMID: 38174910.
Sanchez-Avila M, Amin K, Chauhan A, Geng Z, Mallery S, Snover DC. In Search of Nodular Gastric Antral Vascular Ectasia: A Distinct Entity or Simply Hyperplastic Polyps Arising in Gastric Antral Vascular Ectasia? Arch Pathol Lab Med. 2024 Jan 1;148(1):55-60. doi: 10.5858/arpa.2022-0230-OA. PMID: 37014971.
Torkian P, Wallace S, Lim N, Flanagan S, Golzarian J, Young SJ. Pre-existing Hepatic Encephalopathy: Really a Contraindication to Elective TIPS? Cardiovasc Intervent Radiol. 2024 Jan;47(1):69-77. doi: 10.1007/s00270-023-03566-z. Epub 2023 Oct 5. PMID: 37798432.
Freeman M, Lally L, Teigen L, Graziano E, Shivashankar R, Shmidt E. Hormone Replacement Therapy Is Associated with Disease Activity Improvement among Post-Menopausal Women with Inflammatory Bowel Disease. J Clin Med. 2023 Dec 23;13(1):88. doi: 10.3390/jcm13010088. PMID: 38202098; PMCID: PMC10779540.
Thomson M, Scott A, Trost S, Lake J, Lim N. Letter: Prioritising osteosarcopenia assessment in the ongoing care of patients with cholestatic liver diseases. Authors' reply. Aliment Pharmacol Ther. 2024 Feb;59(4):585-586. doi: 10.1111/apt.17877. PMID: 38247149.
Thomson M, Scott A, Trost S, Lake J, Lim N. Low screening rates and high prevalence of osteoporosis in cirrhosis: A real-world retrospective analysis. Aliment Pharmacol Ther. 2024 Feb;59(4):535-546. doi: 10.1111/apt.17823. Epub 2023 Dec 7. PMID: 38059360.
Roldan GA, Blomker J, Aby ES. Hepatocellular Carcinoma from a Hepatologist's Perspective. Semin Intervent Radiol. 2024 Jan 24;40(6):524-535. doi: 10.1055/s-0043-1777846. PMID: 38274218; PMCID: PMC10807972.
Trikudanathan G, Abdallah M, Munigala S, Vantanasiri K, Jonason D, Faizi N, Schat R, Chauhan A, Freeman ML, Bellin MD. Visceral Fat Predicts New-Onset Diabetes After Necrotizing Pancreatitis. Pancreas. 2024 Jan 25. doi: 10.1097/MPA.0000000000002292. Epub ahead of print. PMID: 38266226.
Mohamed ME, Saqr A, Staley C, Onyeaghala G, Teigen L, Dorr CR, Remmel RP, Guan W, Oetting WS, Matas AJ, Israni AK, Jacobson PA. Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in Transplantation. Transplantation. 2024 Feb 16. doi: 10.1097/TP.0000000000004926. Epub ahead of print. PMID: 38361239.
Hooks G, Lu H, Eaton A, Trikudanathan G, Downs E, Freeman ML, Schwarzenberg SJ, Pruett TL, Chinnakotla S, Ramanathan K, Beilman GJ, Bellin MD. Addressing long-term mortality risk in patients undergoing total pancreatectomy with islet autotransplant (TPIAT): causes of death and risk factors. HPB (Oxford). 2024 Feb 9:S1365-182X(24)00021-2. doi: 10.1016/j.hpb.2024.02.002. Epub ahead of print. PMID: 38368218.
Abdel-Karim TR, Hodges JS, Herold KC, Pruett TL, Ramanathan KV, Hering BJ, Dunn TB, Kirchner VA, Beilman GJ, Bellin MD. Peri-Transplant Inflammation and Long-Term Diabetes Outcomes Were Not Impacted by Either Etanercept or Alpha-1-Antitrypsin Treatment in Islet Autotransplant Recipients. Transpl Int. 2024 Jan 31;37:12320. doi: 10.3389/ti.2024.12320. PMID: 38357216; PMCID: PMC10864605.
Gibbens Y, Lake J, Lim N. A Rare Cause of Acute Liver Failure. Gastroenterology. 2024 Feb 6:S0016-5085(24)00135-5. doi: 10.1053/j.gastro.2024.01.048. Epub ahead of print. PMID: 38331206.
Song GS. Editorial Commentary: The History of Controlling and Treating Infectious Diseases in Ancient China. Curr Med Sci. 2024 Feb;44(1):246. doi: 10.1007/s11596-024-2842-x. PMID: 38393532.
Blake MJ, Steer CJ. Chimeric Livers: Interspecies Blastocyst Complementation and Xenotransplantation for End-Stage Liver Disease. Hepat Med. 2024 Feb 16;16:11-29. doi: 10.2147/HMER.S440697. PMID: 38379783; PMCID: PMC10878318.
Peery AF, Kelly CR, Kao D, Vaughn BP, Lebwohl B, Singh S, Imdad A, Altayar O; AGA Clinical Guidelines Committee. Electronic address: clinicalpractice@gastro.org. AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases. Gastroenterology. 2024 Mar;166(3):409-434. doi: 10.1053/j.gastro.2024.01.008. PMID: 38395525.
Are, V. S., Gromski, M. A., Akisik, F., Vilar-Gomez, E., Lammert, C., Ghabril, M., Vuppalanchi, R., & Chalasani, N. (2024). Primary Sclerosing Cholangitis Limited to Intrahepatic Bile Ducts Has Distinctly Better Prognosis. Digestive diseases and sciences, 10.1007/s10620-023-08260-1. Advance online publication. https://doi.org/10.1007/s10620-023-08260-1
Farrell M, Alseidi A, Byerly S, Fockens P, Giberson FA, Glaser J, Horvath K, Jones D, Luckhurst C, Mowery N, Robinson BRH, Rodriguez A, Singh VK, Siriwardena AK, Vege SS, Trikudanathan G, Visser BC, Voermans RP, Yeh DD, Gelbard RB. A Core Outcome Set for Acute Necrotizing Pancreatitis: an Eastern Association for the Surgery of Trauma Modified Delphi Method Consensus Study. J Trauma Acute Care Surg. 2024 Feb 26. doi: 10.1097/TA.0000000000004281. Epub ahead of print. PMID: 38407209.
Trikudanathan G, Abdallah M, Munigala S, Vantanasiri K, Jonason D, Faizi N, Schat R, Chauhan A, Freeman ML, Bellin MD. Visceral Fat Predicts New-Onset Diabetes After Necrotizing Pancreatitis. Pancreas. 2024 Mar 1;53(3):e240-e246. doi: 10.1097/MPA.0000000000002292. Epub 2024 Jan 25. PMID: 38266226.
Peery AF, Kelly CR, Kao D, Vaughn BP, Lebwohl B, Singh S, Imdad A, Altayar O; AGA Clinical Guidelines Committee. Electronic address: clinicalpractice@gastro.org. AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases. Gastroenterology. 2024 Mar;166(3):409-434. doi: 10.1053/j.gastro.2024.01.008. PMID: 38395525.
Song GS. Editorial Commentary: The History of Controlling and Treating Infectious Diseases in Ancient China. Curr Med Sci. 2024 Feb;44(1):246. doi: 10.1007/s11596-024-2842-x. PMID: 38393532.
Kwong AJ, Kim WR, Lake JR, Schladt DP, Schnellinger EM, Gauntt K, McDermott M, Weiss S, Handarova DK, Snyder JJ, Israni AK. OPTN/SRTR 2022 Annual Data Report: Liver. Am J Transplant. 2024 Feb;24(2S1):S176-S265. doi: 10.1016/j.ajt.2024.01.014. PMID: 38431359.
Sadowsky MJ, Matson M, Mathai PP, Pho M, Staley C, Evert C, Weldy M, Khoruts A. Successful Treatment of Recurrent Clostridioides difficile Infection Using a Novel, Drinkable, Oral Formulation of Fecal Microbiota. Dig Dis Sci. 2024 Mar 8. doi: 10.1007/s10620-024-08351-7. Epub ahead of print. PMID: 38457115.
Ramakrishnan P, Wongjarupong N, Azeem N. Novel use of endoscopic pyloric exclusion and diverting gastrojejunostomy in a patient with duodenal-renal-colonic fistula. VideoGIE. 2023 Nov 14;9(3):134-136. doi: 10.1016/j.vgie.2023.11.005. PMID: 38482481; PMCID: PMC10927705.
Rashidi A, Ebadi M, Rehman TU, Elhusseini H, Kazadi D, Halaweish H, Khan MH, Hoeschen A, Cao Q, Luo X, Kabage AJ, Lopez S, Holtan SG, Weisdorf DJ, Liu C, Ishii S, Khoruts A, Staley C. Long- and short-term effects of fecal microbiota transplantation on antibiotic resistance genes: results from a randomized placebo-controlled trial. Gut Microbes. 2024 Jan-Dec;16(1):2327442. doi: 10.1080/19490976.2024.2327442. Epub 2024 Mar 13. PMID: 38478462; PMCID: PMC10939144.
Sharma P, Shenoy A, Shroff H, Kwong A, Lim N, Pillai A, Devuni D, Haque LY, Balliet W, Serper M. Management of Alcohol-Associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities. Liver Transpl. 2024 Mar 13. doi: 10.1097/LVT.0000000000000362. Epub ahead of print. PMID: 38471008.
Mascarenhas L, Agakishiev D, Freeman M, Hubers S. Purulent pericarditis caused by methicillin-sensitive Staphylococcus aureus bacteriuria. BMC Cardiovasc Disord. 2024 Mar 13;24(1):154. doi: 10.1186/s12872-024-03828-9. PMID: 38481129; PMCID: PMC10935777.